Skip To Main Content
Deze website is alleen bedoeld voor zorgverleners van België en Luxemburg.
Campus
  • Wetenschap
  • Hulpmiddelen
Campus
  • Wetenschap
  • Hulpmiddelen
View Full Results

Artikelen

Sort by

Filters

Resetten
  • Therapeutische gebieden

Autoimmune Type 1 Diabetes

The Type 1 Diabetes (T1D) field is evolving.

Recognition of the presymptomatic stages in T1D is growing.1-4 

The clinical benefits of early detection of T1D are being highlighted.3-4 Programmes focusing on early detection through testing and screening for presymptomatic autoimmune T1D are increasingly offered to risk populations and the general population.1,2

Leer meer

A Paradigm Shift in Early Detection of Autoimmune Type 1 Diabetes

Autoimmune Type 1 diabetes (T1D) is undergoing a fundamental transformation in how the medical community approaches diagnosis and care.

Leer meer

Efluelda® - Seizoensgebonden hooggedoseerd griepvaccin

Leer meer

Airway remodeling in asthma: Why targeting IL-4 and IL-13 matters

Leer meer

Reizigersziekten -Rabiës/Hondsdolheid

Leer meer

Reizigersziekten - Hepatitis A

Leer meer

Reizigersziekten - Gele Koorts

Leer meer

Reizigersziekten

Leer meer

Reizigersziekten - Buiktyfus

Leer meer

Beyfortus® ▼(nirsevimab): effectiveness and public health impact in the real world

Leer meer

Gaucher disease in children

Gaucher disease is an autosomal recessive lysosomal storage disorder caused by pathogenic variants in the GBA1 gene, resulting in deficient activity of the enzyme acid β glucosidase.

Leer meer

DUPIREAL: Two-Year Turning Point with Dupilumab in CRSwNP

The results from the DUPIREAL real-world study reinforce the efficacy of dupilumab demonstrated in the SINUS-24 and SINUS-52 randomized clinical trials and are consistent with the approved SmPC.1,2,3,4 DUPIREAL is the largest long-term real-world study (n=926) evaluating the effectiveness of dupilumab, including treatment response, disease control and remission, in severe uncontrolled CRSwNP over 2 years.2,3

Leer meer